Robert Landewé

65.2k total citations · 12 hit papers
532 papers, 25.0k citations indexed

About

Robert Landewé is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Robert Landewé has authored 532 papers receiving a total of 25.0k indexed citations (citations by other indexed papers that have themselves been cited), including 469 papers in Rheumatology, 180 papers in Immunology and 135 papers in Hematology. Recurrent topics in Robert Landewé's work include Rheumatoid Arthritis Research and Therapies (333 papers), Spondyloarthritis Studies and Treatments (308 papers) and Psoriasis: Treatment and Pathogenesis (148 papers). Robert Landewé is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (333 papers), Spondyloarthritis Studies and Treatments (308 papers) and Psoriasis: Treatment and Pathogenesis (148 papers). Robert Landewé collaborates with scholars based in Netherlands, United States and Germany. Robert Landewé's co-authors include Désirée van der Heijde, Sofía Ramiro, Maxime Dougados, Astrid van Tubergen, Jürgen Braun, Maxime Dougados, Josef S Smolen, Tore K Kvien, Xenofon Baraliakos and Laure Gossec and has published in prestigious journals such as The Lancet, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Robert Landewé

509 papers receiving 24.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dickkopf-1 is a master regulator of joint remodeling

2007 1.0k citations Josef S Smolen, Robert Landewé et al. profile →
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

2008 720 citations Robert Landewé, Joachim Sieper et al. Annals of the Rheumatic Diseases profile →
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

2010 549 citations Pedro Machado, Robert Landewé et al. Annals of the Rheumatic Diseases profile →
Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

2014 542 citations Maarten Boers, Laure Gossec et al. profile →
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

2014 536 citations Sofía Ramiro, Josef S Smolen et al. Annals of the Rheumatic Diseases profile →
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial

2005 500 citations Désirée van der Heijde, Robert Landewé et al. profile →
Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty‐two–week, phase III, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study

2008 465 citations Désirée van der Heijde, Robert Landewé et al. profile →
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis

2013 448 citations Christopher J Edwards, Mikkel Østergaard et al. Annals of the Rheumatic Diseases profile →
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

2009 423 citations Josef S Smolen, Robert Landewé et al. profile →
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept

2008 408 citations Robert Landewé et al. profile →
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis

2020 195 citations Alexandre Sepriano, Andreas Kerschbaumer et al. Annals of the Rheumatic Diseases profile →
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

2021 163 citations Bernard Combe, Désirée van der Heijde et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Robert Landewé

Since Specialization

Citations

This map shows the geographic impact of Robert Landewé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Landewé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Landewé more than expected).

Fields of papers citing papers by Robert Landewé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Landewé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Landewé. The network helps show where Robert Landewé may publish in the future.

Co-authorship network of co-authors of Robert Landewé

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Landewé. A scholar is included among the top collaborators of Robert Landewé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Landewé. Robert Landewé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort 2024 ·Annals of the Rheumatic Diseases ·(unknown), Sofía Ramiro, M. van Lunteren, (unknown), Robert Landewé, Marleen van de Sande, K. M. Fagerli, Inger Jorid Berg, M. van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée van der Heijde, F. van Gaalen	15
2	Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target 2023 ·Lara D. Veeken ·(unknown), (unknown), (unknown), Leonieke van Mens, (unknown), Irene van der Horst‐Bruinsma, Lisa G. M. van Baarsen, Robert Landewé, M. G. H. Van de Sande	3
3	Bone marrow edema in the sacroiliac joints is associated with the development of structural lesions at the same anatomical location over time in patients with axial spondyloarthritis 2023 ·Seminars in Arthritis and Rheumatism ·Santiago Rodrigues-Manica, Alexandre Sepriano, Sofía Ramiro, Robert Landewé, Pascal Claudepierre, Anna Moltó, Maxime Dougados, M. van Lunteren, Désirée van der Heijde	2
4	Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? 2023 ·Annals of the Rheumatic Diseases ·(unknown), Patrick Verschueren, Maarten Boers, Paul Emery, Pascal H P de Jong, Robert Landewé, Willem F. Lems, Josef S Smolen, T. Huizinga, Cornelia F Allaart, Sytske Anne Bergstra	3
5	Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis 2022 ·Annals of the Rheumatic Diseases ·Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Désirée van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme L Hyrich, Kevin Winthrop, Daniel Aletaha, Tanja Stamm, Jan W. Schoones, Josef S Smolen, Robert Landewé	56
6	MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group 2022 ·Annals of the Rheumatic Diseases ·Xenofon Baraliakos, Mikkel Østergaard, R. Lambert, Iris Eshed, Pedro Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martín Rudwaleit, Désirée van der Heijde, Robert Landewé, Walter P. Maksymowych	41
7	Treating spondyloarthritis early: does it matter? Results from a systematic literature review 2022 ·Lara D. Veeken ·(unknown), Diego Benavent, Désirée van der Heijde, Robert Landewé, Denis Poddubnyy, Astrid van Tubergen, Louise Falzon, Victoria Navarro‐Compán, Sofía Ramiro	19
8	Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis 2022 ·Annals of the Rheumatic Diseases ·Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme L Hyrich, Kevin Winthrop, Daniel Aletaha, Tanja Stamm, Jan W. Schoones, Robert Landewé	90
9	Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey 2021 ·The Journal of Rheumatology ·Anne Boel, Victoria Navarro‐Compán, Annelies Boonen, Philip J. Mease, Uta Kiltz, Maxime Dougados, Robert Landewé, Désirée van der Heijde	5
10	Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference 2021 ·RMD Open ·Alexandre Sepriano, Sofía Ramiro, Désirée van der Heijde, Robert Landewé	17
11	OP0079 PRELIMINARY DEFINITION OF A POSITIVE MRI FOR STRUCTURAL LESIONS IN THE SACROILIAC JOINTS IN AXIAL SPONDYLOARTHRITIS 2020 ·Annals of the Rheumatic Diseases ·Walter P. Maksymowych, Xenofon Baraliakos, Ulrich Weber, Pedro Machado, Susanne Juhl Pedersen, Joachim Sieper, Stephanie Wichuk, Denis Poddubnyy, Martín Rudwaleit, Désirée van der Heijde, Robert Landewé, Joel Paschke, R. Lambert, Mikkel Østergaard	1
12	EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 2020 ·Annals of the Rheumatic Diseases ·Robert Landewé, Pedro Machado, Féline P B Kroon, Hans Bijlsma, Gerd R Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec, Annamaria Iagnocco, John D. Isaacs, Xavier Mariette, Iain B. McInnes, Ulf Müeller-Ladner, Peter Openshaw, Josef S Smolen, Tanja Stamm, Dieter Wiek, Hendrik Schulze‐Koops	153
13	Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5 2019 ·Lara D. Veeken ·Désirée van der Heijde, Philip J. Mease, Robert Landewé, Proton Rahman, Hasan Tahir, Atul Singhal, (unknown), Sandra Navarra, Xuan Zhu, Gregory Ligozio, Aimee Readie, Shephard Mpofu, Luminita Pricop	45
14	Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis 2018 ·Annals of the Rheumatic Diseases ·Maxime Dougados, Walter P. Maksymowych, Robert Landewé, Anna Moltó, Pascal Claudepierre, Manouk de Hooge, R. Lambert, R. Bonin, Jack F. Bukowski, Heather Jones, I. Logeart, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Désirée van der Heijde	33
15	Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis 2015 ·Arthritis Research & Therapy ·Robert Landewé, Josef S Smolen, S. Florentinus, Su Chen, B. Guérette, Désirée van der Heijde	11
16	Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis? 2015 ·Annals of the Rheumatic Diseases ·Manouk de Hooge, Rosaline van den Berg, Victoria Navarro‐Compán, M. Reijnierse, F. van Gaalen, K. M. Fagerli, Robert Landewé, M. van Oosterhout, Roberta Ramonda, T. Huizinga, Désirée van der Heijde	86
17	Spinal Mobility Measures in Normal Individuals - the Mobility Study 2012 ·Data Archiving and Networked Services (DANS) ·S. Ramiro, C. Stolwijk, Astrid van Tubergen, (unknown), Robert Landewé	1
18	Validation of Prognostic Biomarkers for RA: Testing of 14-3-3 Eta According to the Omeract Soluble Biomarker Criteria 2012 ·Data Archiving and Networked Services (DANS) ·Walter P. Maksymowych, (unknown), Robert Landewé, (unknown), Joan M. Bathon, (unknown), Vivian P. Bykerk, Mikkel Østergaard, Hilde Berner Hammer, (unknown), (unknown), Oliver FitzGerald, Christopher T. Ritchlin, Dafna D. Gladman, Philip J. Mease, (unknown), M. Backhaus, Bernard Combe, (unknown), A. Marotta	2
19	In Ankylosing Spondylitis, a Decrease in MRI Spinal Inflammation Predicts Improvement in Spinal Mobility Independently of Patient Reported Symptomatic Improvement 2012 ·Data Archiving and Networked Services (DANS) ·Patrícia Maria Abreu Machado, Robert Landewé, Jürgen Braun, Xenofon Baraliakos, Kay‐Geert Hermann, Benjamin Hsu, David W. Baker, (unknown)	0
20	OMERACT Magnetic Resonance Imaging Initiative on Structural and Inflammatory Lesions in Ankylosing Spondylitis — Report of a Special Interest Group at OMERACT 10 on Sacroiliac Joint and Spine Lesions 2011 ·The Journal of Rheumatology ·Xenofon Baraliakos, Désirée van der Heijde, Jürgen Braun, Robert Landewé	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact